Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

PharmaBlock buys Porton drug chemical plant

by Jean-François Tremblay
October 7, 2018 | A version of this story appeared in Volume 96, Issue 40

 

PharmaBlock Sciences has bought a chemical production facility from Porton Pharma Solutions. Located in Shangyu, China, in the east coast province of Zhejiang, the facility can produce drug intermediates under Good Manufacturing Practices standards. Porton is currently not operating the facility, whereas PharmaBlock says it needs more capacity because some of the chemicals it has been supplying in research quantities to drug company scientists are needed in larger amounts. It plans to expand the plant soon after taking possession.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.